Opioids sales were responsible for roughly $403 million of Endo’s overall revenues in 2012, $657 million in 2014, and $486 million of Endo’s $4 billion in sales in 2016. Opioids sales constituted a substantial portion of Endo’s overall revenues. (“PPI”).Įndo and its subsidiaries have been substantial manufacturers of opioids in the U.S., with the State of New York (“New York”) comprising a significant part of Endo’s opioid market. (“EPI”), Par Pharmaceutical Companies, Inc. and internationally, including both generic and branded opioid products.Įndo operates through several subsidiaries engaged in the opioid market, including Endo Health Solutions Inc. The Company manufactures and sells generic and branded pharmaceuticals in the U.S. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.Įndo was founded in 1920 and is headquartered in Dublin, Ireland. A copy of the Complaint can be obtained at To discuss this action, contact Robert S. If you are a shareholder who purchased Endo securities during the class period, you have until August 18, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. The class action, filed in United States District Court for the District of New Jersey, and indexed under 20-cv-07536, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired Endo securities between August 8, 2017, and June 10, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
NEW YORK, J(GLOBE NEWSWIRE) - Pomerantz LLP announces that a class action lawsuit has been filed against Endo International plc (“Endo” or the “Company”) (NASDAQ: ENDP) and certain of its officers.
0 kommentar(er)
